Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

amrubicin × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Extensive Stage Small Cell Lung Cancer (ES-SCLC) 1

Interventions

Specimen Handling 414 Magnetic Resonance Spectroscopy 337 pembrolizumab 298 Biopsy 231 Carboplatin 227 Cisplatin 190 Cyclophosphamide 172 Nivolumab 169 Gemcitabine 166 Paclitaxel 153 Bevacizumab 125 Radiotherapy 116 atezolizumab 101 Docetaxel 98 Dexamethasone 98 venetoclax 93 fludarabine 93 Oxaliplatin 90 Rituximab 87 durvalumab 85 Radiation 82 Fluorouracil 82 Pemetrexed 81 Doxorubicin 80 Prednisone 75 Ipilimumab 75 Taxes 72 Capecitabine 69 X-Rays 67 Lenalidomide 67

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06801834 2026-03-19

EVOKE-SCLC-04

Gilead Sciences

Phase 3 Recruiting

Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡